Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Downgrades Overstock.com to Hold

Needham analyst Anna Andreeva downgrades Overstock.com (NASDAQ:OSTK) from Buy to Hold.
byBenzinga Newsdesk
January 4, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Anna Andreeva downgrades Overstock.com (NASDAQ:OSTK) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GSK Announced Phase IIa Study Results for a New First-in-class Candidate Medicine for Patients With Tuberculosis Showed Early Bactericidal Activity With Low, Once-daily Oral Dose After 14 Days of Treatment in Users With Drug-susceptible Pulmonary TB

By Charles Gross
November 14, 7:17 AM
GSK plc (LSE/NYSE: GSK) today announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well tolerated and showed early bactericidal activity with a low, once-daily oral dose after 14 days of treatment in participants with drug-susceptible pulmonary tuberculosis.

GSK